Since UHRF2 protein levels are upregulated in HBV-associated HCC as well as in HBV-positive hepatoma cells, we identified the UHRF2 substrates which may modulate the process of HBV-associated liver diseases from hepatitis to HBV-associated HCC. The gene discussed is UHRF2; the disease is hepatocellular carcinoma.